Search Within

William P Tew

  1. "Rachel Grisham"
Formats
  1. Journal Article (23)
  2. Meeting Abstract (22)
  3. Book Section (1)
Groups
  1. Department of Medicine (46)
  2. GDMT, Medicine (46)
  3. Gynecologic Medicine Service (46)
  4. Gynecology Disease Management Team (46)
  5. Solid Tumor Oncology Division (46)
  6. Hematologic Malignancies, Division of (45)

More Groups

People
  1. Rachel Grisham (46)
  2. Roisin O'Cearbhaill (42)
  3. Carol Aghajanian (30)
  4. Alexia Iasonos (26)
  5. Dennis Chi (24)
  6. Ginger Gardner (22)

More People

Years
  1. 2025 (2)
  2. 2024 (6)
  3. 2023 (6)
  4. 2022 (4)
  5. 2021 (6)
  6. 2020 (10)

More Years

Publications
  1. Gynecologic Oncology (19)
  2. Journal of Clinical Oncology (12)
  3. International Journal of Gynecological Cancer (6)
  4. Clinical Cancer Research (2)
  5. American Journal of Roentgenology (1)
  6. Cancer (1)

More Publications

Publishers
  1. Elsevier Inc. (19)
  2. American Society of Clinical Oncology (13)
  3. Lippincott Williams & Wilkins (6)
  4. American Association for Cancer Research (4)
  5. American Roentgen Ray Society (1)
  6. Nature Publishing Group (1)

More Publishers

Results (46)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial
    Journal Article

    Praiss, A. M.; Zhou, Q.; Iasonos, A.; Moukarzel, L.; Dessources, K.; Soldan, K.; Su, K.; Sonoda, Y.; Roche, K. L.; Gardner, G. J.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management
    Journal Article

    Liu, Y. L.; Manning-Geist, B. L.; Knezevic, A.; Deng, L.; Bromberg, M.; Funt, S. A.; Meisel, J. L.; Zivanovic, O.; Roche, K. L.; Sonoda, Y.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level – A Memorial Sloan Kettering Cancer Center team ovary study
    Journal Article

    Kahn, R. M.; McMinn, E.; Yeoshoua, E.; Boerner, T.; Zhou, Q.; Iasonos, A.; Long Roche, K.; Zivanovic, O.; Gardner, G. J.; Sonoda, Y.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to long-term survivors
    Journal Article

    Kahn, R.; Filippova, O.; Gordhandas, S.; An, A.; Straubhar, A. M.; Zivanovic, O.; Gardner, G. J.; O'Cearbhaill, R. E.; Tew, W. P.; Grisham, R. N.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Creating a multidisciplinary protocol for the administration of hyperthermic intraperitoneal chemotherapy with cisplatin: A single-institution experience
    Meeting Abstract

    Praiss, A.; Moukarzel, L.; Dessources, K.; Sonoda, Y.; Roche, K. L.; Gardner, G.; Tew, W.; Grisham, R.; Chi, D.; O'Cearbhaill, R.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Postoperative morbidity after secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer: An exploratory analysis of a randomized phase II study evaluating hyperthermic intraperitoneal chemotherapy
    Meeting Abstract

    Praiss, A.; Moukarzel, L.; Chi, D.; Sonoda, Y.; Roche, K. L.; Gardner, G.; Tew, W.; Grisham, R.; O'Cearbhaill, R.; Zivanovic, O.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer
    Journal Article

    Manning-Geist, B. L.; Gordhandas, S. B.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; O'Cearbhaill, R. E.; Zamarin, D.; Lichtman, S. M.; Sabbatini, P. J.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Secondary cytoreduction and carboplatin hyperthermic intraperitoneal chemotherapy for platinum-sensitive recurrent ovarian cancer: An MSK Team Ovary phase II study
    Journal Article

    Zivanovic, O.; Chi, D. S.; Zhou, Q.; Iasonos, A.; Konner, J. A.; Makker, V.; Grisham, R. N.; Brown, A. K.; Nerenstone, S.; Diaz, J. P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy
    Journal Article

    Basaran, D.; Boerner, T.; Suhner, J.; Sassine, D.; Liu, Y.; Grisham, R. N.; Tew, W. P.; Gardner, G. J.; Zivanovic, O.; Sonoda, Y.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save